RE
Roberts Eiry
Directeur Médical
OtherF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Roberts Eiry, Directeur Médical. Insider active across 3 companies, notably Amicus Therapeutics, INC.. Aggregated, 24 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €3.8m. Activity tracked since 10 June 2021. The latest transaction was disclosed on 22 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Roberts Eiry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
45,871 股0Common Shares, No Par ValueSEC:0000885590-26-000082:0
76,275 股@ US$14.500.024% mcap100.0% 占其流量Common StockSEC:0001193125-26-182275:0
20,414 股0Common StockSEC:0000950170-25-083215:0
2,113 股0Common StockSEC:0000914475-25-000069:0
1,860 股0Common StockSEC:0000914475-25-000051:0
2,769 股0Common StockSEC:0000914475-25-000029:0
5,140 股@ US$77.814.4% 占其流量Common StockSEC:0000914475-24-000220:0
11,847 股0Common StockSEC:0000950170-24-071007:0
1,114 股@ US$132.96391.6% 占其流量Common StockSEC:0000914475-24-000076:0
1,121 股@ US$142.23561.8% 占其流量Common StockSEC:0000914475-24-000049:0
1,457 股@ US$140.79062.2% 占其流量Common StockSEC:0000914475-24-000031:0
10,000 股@ US$126.744813.7% 占其流量Common StockSEC:0001209191-23-059774:0
6,978 股@ US$81.056.2% 占其流量Common StockSEC:0001209191-23-058683:0
38,722 股@ US$77.8133.2% 占其流量Common StockSEC:0001209191-23-058116:0
8,396 股@ US$77.817.2% 占其流量Common StockSEC:0001209191-23-057986:0
3,198 股@ US$107.37583.7% 占其流量Common StockSEC:0001209191-23-047140:0
8,584 股0Common StockSEC:0001209191-23-036422:0
14,400 股@ US$103.476316.0% 占其流量Common StockSEC:0001209191-23-025763:0
1,121 股@ US$105.80041.3% 占其流量Common StockSEC:0001209191-23-007916:0
1,457 股@ US$109.98871.8% 占其流量Common StockSEC:0001209191-23-006282:0
12,671 股0Common StockSEC:0001209191-22-035847:0
1,623 股@ US$80.76761.4% 占其流量Common StockSEC:0001209191-22-008216:0
2,632 股@ US$74.50142.1% 占其流量Common StockSEC:0001209191-22-003104:0
22,759 股0Common StockSEC:0001209191-21-040374:0
About Roberts Eiry
ROBERTS EIRY is Chief Medical Officer. He has 24 filings in total, and in the recent filings we hold, the transactions are sales for a total of EUR 4777220, over the period from 2021-06-14 to 2026-05-26. The main filings concern Neurocrine Biosciences INC, Amicus Therapeutics, INC., and Bausch Health Companies Inc.